Aberrant methylation of p16(INK4a) and deletion of p15(INK4b) a frequent events in human esophageal cancer in Linxian, China

Carcinogenesis

Volumn 20, Issue 1, 1999, Pages 77-84

  Xing, Eric Poe ^a   Nie, Yan ^a   Wang, Li Dong ^b   Yang, Guang Yu ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MICROSATELLITE DNA; PROTEIN P15; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CARCINOGENESIS; CHINA; CHROMOSOME 9P; CPG ISLAND; DNA METHYLATION; ESOPHAGUS CANCER; GENE DELETION; GENE FREQUENCY; GENE INACTIVATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; CELL CYCLE; CHEMISTRY; CHROMOSOME 9; ESOPHAGUS TUMOR; GENETICS; MUTATION; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CHINA; CHROMOSOMES, HUMAN, PAIR 9; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE DELETION; GENES, P16; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0032587192     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.1.77     Document Type: Article

References (33)

1. Hartwell, L.H. and Kastan, M.B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
2. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-133.
3. Xiong, Y., Zhang, H. and Beach, D. (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 7, 1572-1583.
4. Reynisdottir, I. and Massague, J. (1997) The subcellular locations of p15(ink4b) and p27(kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev., 11, 492-503.
5. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day, R.S., III, Johnson, B.E. and Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
6. Platz, A., Hansson, J., Mansson-Brahme, E., Lagerlof, B., Linder, S., Lundqvist, E., Sevigny, P., Inganas, M. and Ringborg, U. (1997) Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J. Natl Cancer Inst., 89, 697-702.
7. Cairns, C., Mao, L., Merlo, A., Lee, D.J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J.E. and Sidransky, D. (1994) Rates of p16 (MTS1) mutations in primary tumor with 9p loss. Science, 265, 415-416.
8. Shigemasa, K., Hu, C., West, C.M., Clarke, J., Parham, G.P., Parmley, T.H., Korourian, S., Baker, V.V. and O'Brien, T.J. (1997) p16 overexpression: a potential early indicator of transformation in ovarian carcinoma. J. Soc. Gynecol. Investig., 4, 95-102.
9. Barrett, M.T., Sanchez, C.A., Galipeau, P.C., Neshat, K., Emond, M. and Reid, B.J. (1996) Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplaslic progression in Barrett's esophagus. Oncogene, 13, 1867-1873.
10. Walker, D.G., Duan, W., Povovic, E.A., Kaye, A.H., Tomlinson, F.H. and Lavin, M. (1995) Homozygous deletion of the multiple tumor suppressor gene in the progression of human astrocytomas. Cancer Res., 55, 20-23.
11. Okamoto, A., Hussain, S.P., Hagiwara, K. et al. (1995) Mutations in the p16INK4A/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451.
12. Quelle, D.E., Zindy, F., Ashmun, R.A. and Sherr, C.J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000.
13. Flores, J.F., Walker, G.J., Glendening, J.M. et al. (1996) Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res., 56, 5023-5032.
14. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
15. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/ CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692.
16. Gonzalez-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T., Beart, R.W., Van Tornout, J.M. and Jones, P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535.
17. Herman, J.G., Jen, J., Merlo, A. and Baylin, S.B. (1996) Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res., 56, 722-727.
18. Herman, J.G., Civin, C.I., Issa, J.J., Collector, M.I., Sharkis, S.J. and Baylin, S.B. (1997) Distinct pattern of inactivation of p15INK4B and p16INK4A characterize the major types of hemotological malignancies. Cancer Res., 57, 837-841.
19. Chan, W.C., Tang, C.M.C., Lau, K.W. and Lung, M.L. (1995) p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong. Cancer Lett., 115, 201-206.
20. Tanaka, H., Shimada, Y., Imamura, M., Shibagaki, I. and Ishizaki, K. (1997) Multiple types of aberrations in the p16(INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. Int. J. Cancer, 70, 437-442.
21. Maesawa, C., Tamura, G., Nishizuka, S., Ogasawara, S., Ishida, K., Terashima, M., Sakata, K., Sato, N., Saito, K. and Satodate, R. (1996) Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res., 56, 3875-3878.
22. Yang, G.-Y., Zhang, Z., Jie, L., Seril, D., Wang, L.-D., Goldstein, S. and Yang, C.S. (1997) Immunohistochemical studies of Waf1p21, p16, pRb, and p53 in human esophageal carcinoma and neighboring epithelia from a high-risk area in northern China. Int. J. Cancer, 72, 1-6.
23. Shibagaki, I., Shimada, Y., Wagata, T., Ikenaga, M., Imamura, M. and Ishizaki, K. (1994) Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54, 2996-3000.
24. Muzeau, F., Flejou, J.F., Thomas, G. and Hamelin, R. (1997) Loss of heterozygosity on chromosome 9 and p 16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int. J. Cancer, 72, 27-30.
25. Gao, H., Wang, L.-D., Zhou, Q., Hong, J.-Y., Huang, T.-Y. and Yang, C.S. (1994) p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res., 54, 4342-4346.
26. Issa, J., Baylin, S.B. and Herman, J.G. (1997) DNA methylation changes in hematologic malignancies - biologic and clinical implications. Leukemia, 11, Suppl. S7-S11.
27. Wong, D.J., Barrett, M.T., Stoger, R., Emond, M.J. and Reid, B.J. (1997) p16ink4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res., 57, 2619-2622.
28. Glendening, J.M., Flores, J.F., Walker, G.J., Stone, S., Albino, A.P. and Fountain, J.W. (1995) Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient. Cancer Res., 55, 5531-5535.
29. Gonzalez, M.V., Pello, M.F., Lopez-Larrea, C., Suarez, C., Menendez, M.J. and Coto, E. (1997) Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J. Clin. Pathol., 50, 509-512.
30. Yamada, Y., Hatta, Y., Murata, K. et al. (1997) Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J. Clin. Oncol., 15, 1778-1785.
31. Califano, J., Riet, P., Westra, W. et al. (1996) Genetic progression model for head and neck cancer: implication for field cancerization. Cancer Res., 56, 2488-2492.
32. ARF. Cell, 91, 555-558.
33. Hannon, G.J. and Beach, D. (1994) p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.